ANALYSIS BY BUSINESS SEGMENT | Revenue | Adjusted operating profit | ||||
2021 | 2022 | 2023 | 2021 | 2022 | 2023 | |
£m | £m | £m | £m | £m | £m | |
Risk | 2,474 | 2,909 | 3,133 | 915 | 1,078 | 1,165 |
Scientific, Technical & Medical | 2,649 | 2,909 | 3,062 | 1,001 | 1,100 | 1,165 |
Legal | 1,587 | 1,782 | 1,851 | 326 | 372 | 393 |
Exhibitions | 534 | 953 | 1,115 | 10 | 162 | 319 |
Sub-total | 7,244 | 8,553 | 9,161 | 2,252 | 2,712 | 3,042 |
Unallocated central costs and other operating items | - | - | - | (42) | (29) | (12) |
Total | 7,244 | 8,553 | 9,161 | 2,210 | 2,683 | 3,030 |
2021 | Scientific, Technical | ||||
Risk | & Medical | Legal | Exhibitions | Total | |
Revenue by geographical market | |||||
North America | 1,957 | 1,215 | 1,049 | 100 | 4,321 |
Europe | 342 | 602 | 341 | 187 | 1,472 |
Rest of world | 175 | 832 | 197 | 247 | 1,451 |
Total revenue | 2,474 | 2,649 | 1,587 | 534 | 7,244 |
Revenue by format | |||||
Electronic | 2,453 | 2,334 | 1,385 | 58 | 6,230 |
Face-to-face | 13 | 2 | 9 | 476 | 500 |
Print | 8 | 313 | 193 | - | 514 |
Total revenue | 2,474 | 2,649 | 1,587 | 534 | 7,244 |
Revenue by type | |||||
Subscriptions | 989 | 1,970 | 1,255 | - | 4,214 |
Transactional | 1,485 | 679 | 332 | 534 | 3,030 |
Total revenue | 2,474 | 2,649 | 1,587 | 534 | 7,244 |
2022 | Scientific, Technical | ||||
Risk | & Medical | Legal | Exhibitions | Total | |
Revenue by geographical market | |||||
North America | 2,317 | 1,391 | 1,213 | 180 | 5,101 |
Europe | 384 | 614 | 357 | 445 | 1,800 |
Rest of world | 208 | 904 | 212 | 328 | 1,652 |
Total revenue | 2,909 | 2,909 | 1,782 | 953 | 8,553 |
Revenue by format | |||||
Electronic | 2,890 | 2,573 | 1,582 | 67 | 7,112 |
Face-to-face | 11 | 5 | 10 | 886 | 912 |
Print | 8 | 331 | 190 | - | 529 |
Total revenue | 2,909 | 2,909 | 1,782 | 953 | 8,553 |
Revenue by type | |||||
Subscriptions | 1,135 | 2,139 | 1,381 | - | 4,655 |
Transactional | 1,774 | 770 | 401 | 953 | 3,898 |
Total revenue | 2,909 | 2,909 | 1,782 | 953 | 8,553 |
2023 | Scientific, Technical | ||||
Risk | & Medical | Legal | Exhibitions | Total | |
Revenue by geographical market | |||||
North America | 2,476 | 1,439 | 1,254 | 217 | 5,386 |
Europe* | 429 | 666 | 386 | 427 | 1,908 |
Rest of world | 228 | 957 | 211 | 471 | 1,867 |
Total revenue | 3,133 | 3,062 | 1,851 | 1,115 | 9,161 |
Revenue by format | |||||
Electronic | 3,111 | 2,762 | 1,667 | 85 | 7,625 |
Face-to-face | 14 | 7 | 9 | 1,030 | 1,060 |
Print | 8 | 293 | 175 | - | 476 |
Total revenue | 3,133 | 3,062 | 1,851 | 1,115 | 9,161 |
Revenue by type | |||||
Subscriptions | 1,255 | 2,261 | 1,460 | - | 4,976 |
Transactional | 1,878 | 801 | 391 | 1,115 | 4,185 |
Total revenue | 3,133 | 3,062 | 1,851 | 1,115 | 9,161 |
ANALYSIS OF REVENUE BY GEOGRAPHICAL ORIGIN | 2021 | 2022 | 2023 |
£m | £m | £m | |
North America | 4,204 | 5,002 | 5,325 |
Europe | 2,547 | 2,974 | 3,117 |
Rest of world | 493 | 577 | 719 |
Total | 7,244 | 8,553 | 9,161 |
ANALYSIS BY BUSINESS | Expenditure on | |||||||||||
SEGMENT | acquired goodwill and | Capital expenditure | Amortisation of acquired | Total depreciation and | ||||||||
intangible assets | additions | intangible assets | other amortisation | |||||||||
2021 | 2022 | 2023 | 2021 | 2022 | 2023 | 2021 | 2022 | 2023 | 2021 | 2022 | 2023 | |
£m | £m | £m | £m | £m | £m | £m | £m | £m | £m | £m | £m | |
Risk | 208 | 155 | 79 | 83 | 122 | 139 | 186 | 204 | 194 | 93 | 94 | 92 |
Scientific, Technical & | ||||||||||||
Medical | 58 | 206 | 3 | 87 | 103 | 108 | 63 | 60 | 59 | 144 | 119 | 136 |
Legal | 12 | 33 | 42 | 145 | 186 | 193 | 27 | 12 | 11 | 220 | 229 | 247 |
Exhibitions | 9 | - | 8 | 24 | 28 | 37 | 22 | 20 | 16 | 30 | 49 | 39 |
Total | 287 | 394 | 132 | 339 | 439 | 477 | 298 | 296 | 280 | 487 | 491 | 514 |
ANALYSIS OF NON-CURRENT ASSETS BY GEOGRAPHICAL LOCATION | 2022 | 2023 |
£m | £m | |
North America | 9,821 | 9,149 |
Europe | 2,193 | 2,141 |
Rest of world | 460 | 459 |
Total | 12,474 | 11,749 |
RECONCILIATION OF OPERATING PROFIT TO ADJUSTED OPERATING PROFIT | 2021 | 2022 | 2023 |
£m | £m | £m | |
Operating profit | 1,884 | 2,323 | 2,682 |
Adjustments: | |||
Amortisation of acquired intangible assets | 298 | 296 | 280 |
Acquisition-related items | 21 | 62 | 56 |
Reclassification of tax in joint ventures and associates | 7 | 4 | 12 |
Reclassification of finance income in joint ventures and associates | - | (2) | - |
Adjusted operating profit | 2,210 | 2,683 | 3,030 |
2021 | 2022 | 2023 | ||
Note | £m | £m | £m | |
Total staff costs | 5 | 2,549 | 2,906 | 3,108 |
Depreciation and amortisation | ||||
Amortisation of acquired intangible assets | 14 | 297 | 294 | 279 |
Share of joint ventures and associates' amortisation of acquired intangible assets | 1 | 2 | 1 | |
Amortisation of acquired intangible assets including joint ventures and | ||||
associates' share | 298 | 296 | 280 | |
Amortisation of internally developed intangible assets | 14 | 295 | 309 | 330 |
Depreciation of property, plant and equipment | 16 | 52 | 47 | 43 |
Depreciation of right-of-use assets | 80 | 63 | 65 | |
Pre-publication amortisation | 60 | 72 | 76 | |
Total depreciation and other amortisation | 2 | 487 | 491 | 514 |
Total depreciation and amortisation (including amortisation of acquired | ||||
intangibles) | 785 | 787 | 794 | |
Other expenses and income | ||||
Cost of sales including pre-publication costs and inventory expenses | 2,562 | 3,045 | 3,216 | |
Short-term and low value lease expenses | 21 | 19 | 18 |
2021 | 2022 | 2023 | |
£m | £m | £m | |
Auditor’s remuneration | |||
Payable to the auditors of RELX PLC | 0.9 | 0.9 | 0.9 |
Payable to the auditors of the Group’s subsidiaries | 7.7 | 8.4 | 7.5 |
Audit services | 8.6 | 9.3 | 8.4 |
Audit-related assurance services | 0.5 | 0.6 | 0.5 |
Other services* | - | - | 0.2 |
Total auditor’s remuneration | 9.1 | 9.9 | 9.1 |
2021 | 2022 | 2023 | ||
Note | £m | £m | £m | |
Staff costs | ||||
Wages and salaries | 2,157 | 2,453 | 2,636 | |
Social security costs | 214 | 257 | 274 | |
Pensions | 6 | 133 | 150 | 142 |
Share based remuneration | 45 | 46 | 56 | |
Total staff costs | 2,549 | 2,906 | 3,108 |
NUMBER OF PEOPLE EMPLOYED: FULL-TIME EQUIVALENTS* | At 31 December | Average during the year | ||||
2021 | 2022 | 2023 | 2021 | 2022 | 2023 | |
Business segment | ||||||
Risk | 10,000 | 10,800 | 11,100 | 9,800 | 10,400 | 10,900 |
Scientific, Technical & Medical | 8,700 | 9,500 | 9,500 | 8,600 | 9,300 | 9,600 |
Legal | 10,500 | 11,300 | 11,800 | 10,300 | 10,900 | 11,900 |
Exhibitions | 3,500 | 3,300 | 3,500 | 3,600 | 3,300 | 3,500 |
Sub-total | 32,700 | 34,900 | 35,900 | 32,300 | 33,900 | 35,900 |
Corporate/shared functions | 800 | 800 | 600 | 800 | 800 | 600 |
Total | 33,500 | 35,700 | 36,500 | 33,100 | 34,700 | 36,500 |
Geographical location | ||||||
North America | 14,000 | 14,900 | 14,900 | 13,900 | 14,500 | 15,000 |
Europe | 9,300 | 9,800 | 10,000 | 9,400 | 9,500 | 9,900 |
Rest of world | 10,200 | 11,000 | 11,600 | 9,800 | 10,700 | 11,600 |
Total | 33,500 | 35,700 | 36,500 | 33,100 | 34,700 | 36,500 |
2021 |
2022 |
2023 |
|
£m |
£m |
£m |
|
Defined benefit pension expense |
24 |
19 |
5 |
Defined contribution pension expense |
109 |
131 |
137 |
Total |
133 |
150 |
142 |
2021 | 2022 | 2023 | |||||||
UK | US | Total | UK | US | Total | UK | US | Total | |
£m | £m | £m | £m | £m | £m | £m | £m | £m | |
Service cost | 21 | 3 | 24 | 16 | 3 | 19 | 2 | 3 | 5 |
Defined benefit pension expense | 21 | 3 | 24 | 16 | 3 | 19 | 2 | 3 | 5 |
Net interest on net defined benefit obligation | 8 | 1 | 9 | 4 | 1 | 5 | 1 | - | 1 |
Net defined benefit pension expense | 29 | 4 | 33 | 20 | 4 | 24 | 3 | 3 | 6 |
AS AT 31 DECEMBER | 2021 | 2022 | 2023 | |||
UK | US | UK | US | UK | US | |
Discount rate | 1.95 % | 2.80 % | 4.90 % | 5.35 % | 4.60 % | 5.05 % |
Inflation | 3.30 % | 2.50 % | 3.20 % | 2.50 % | 3.05 % | 2.50 % |
AS AT 31 DECEMBER 2021 | Male average life | Female average | ||
expectancy | life expectancy | |||
UK | US | UK | US | |
Member currently aged 60 years | 85 | 86 | 89 | 88 |
Member currently aged 45 years | 87 | 86 | 90 | 89 |
AS AT 31 DECEMBER 2022 | Male average life | Female average | ||
expectancy | life expectancy | |||
UK | US | UK | US | |
Member currently aged 60 years | 85 | 86 | 89 | 88 |
Member currently aged 45 years | 87 | 86 | 90 | 89 |
AS AT 31 DECEMBER 2023 | Male average life | Female average | ||
expectancy | life expectancy | |||
UK | US | UK | US | |
Member currently aged 60 years | 85 | 86 | 88 | 88 |
Member currently aged 45 years | 86 | 86 | 90 | 89 |
2022 | 2023 | |||||
UK | US | Total | UK | US | Total | |
£m | £m | £m | £m | £m | £m | |
Defined benefit obligation | ||||||
At start of yea r | (4,629) | (992) | (5,621) | (2,887) | (865) | (3,752) |
Service cost | (16) | (3) | (19) | (2) | (3) | (5) |
Interest on pension scheme liabilities | (89) | (29) | (118) | (138) | (43) | (181) |
Actuarial gains/(losses) on financial assumptions | 1,809 | 224 | 2,033 | (61) | (19) | (80) |
Actuarial gains/(losses) arising from experience | ||||||
assumptions | (81) | (7) | (88) | (16) | 5 | (11) |
Contributions by employees | (8) | - | (8) | (8) | - | (8) |
Benefits paid | 127 | 54 | 181 | 128 | 57 | 185 |
Exchange translation differences | - | (112) | (112) | - | 46 | 46 |
At end of year | (2,887) | (865) | (3,752) | (2,984) | (822) | (3,806) |
Fair value of scheme assets | ||||||
At start of yea r | 4,390 | 1,007 | 5,397 | 2,852 | 854 | 3,706 |
Interest income on plan assets | 85 | 28 | 113 | 137 | 43 | 180 |
Return on assets excluding amounts included in | ||||||
interest income | (1,573) | (247) | (1,820) | 1 | 34 | 35 |
Contributions by employer | 69 | 6 | 75 | 67 | 6 | 73 |
Contributions by employees | 8 | - | 8 | 8 | - | 8 |
Benefits paid | (127) | (54) | (181) | (128) | (57) | (185) |
Exchange translation differences | - | 114 | 114 | - | (46) | (46) |
At end of year | 2,852 | 854 | 3,706 | 2,937 | 834 | 3,771 |
Opening net balance | (239) | 15 | (224) | (35) | (11) | (46) |
Service cost | (16) | (3) | (19) | (2) | (3) | (5) |
Net interest on net defined benefit obligation | (4) | (1) | (5) | (1) | - | (1) |
Contributions by employer | 69 | 6 | 75 | 67 | 6 | 73 |
Actuarial gains/(losses) | 155 | (30) | 125 | (76) | 20 | (56) |
Exchange translation differences | - | 2 | 2 | - | - | - |
Net pension balance | (35) | (11) | (46) | (47) | 12 | (35) |
Impact of asset ceiling | (5) | (4) | (9) | (6) | (22) | (28) |
Overall net pension balance | (40) | (15) | (55) | (53) | (10) | (63) |
2022 | 2023 | |
£m | £m | |
Net pension asset recognised | 129 | 119 |
Net pension obligation | (184) | (182) |
Overall net pension balance | (55) | (63) |
2021 | 2022 | 2023 | |
£m | £m | £m | |
Gains and losses arising during the year: | |||
Experience losses on scheme liabilities | (153) | (88) | (11) |
Experience gains/(losses) on scheme assets | 279 | (1,820) | 35 |
Actuarial (losses)/gains on the present value of scheme liabilities due to changes in: | |||
– discount rates | 463 | 2,000 | (145) |
– inflation | (290) | 32 | 15 |
– other actuarial assumptions | 20 | 1 | 50 |
319 | 125 | (56) |
FAIR VALUE OF SCHEME ASSETS | 2022 | 2023 | ||||
UK | US | Total | UK | US | Total | |
£m | £m | £m | £m | £m | £m | |
Equities ¹ | 272 | 4 | 276 | 431 | 3 | 434 |
Liability matching assets ² | 899 | 802 | 1,701 | 1,760 | 804 | 2,564 |
Property funds and ground leases ³ | 651 | - | 651 | 406 | - | 406 |
Direct lending | 241 | - | 241 | 229 | - | 229 |
Cash and cash equivalents ⁴ | 788 | 17 | 805 | 98 | 27 | 125 |
Other | 1 | 31 | 32 | 13 | - | 13 |
Total | 2,852 | 854 | 3,706 | 2,937 | 834 | 3,771 |
£m | |
Increase/decrease of 0.5% in discount rate | 231 |
Increase/decrease of 0.25% in the expected inflation rate | 69 |
Increase/decrease of one year in assumed life expectancy | 101 |
2021 | 2022 | 2023 | |
£m | £m | £m | |
Interest on short-term bank loans, overdrafts and commercial paper | (11) | (19) | (31) |
Interest on term debt | (106) | (157) | (263) |
Interest on lease liabilities | (8) | (6) | (6) |
Total borrowing costs | (125) | (182) | (300) |
Losses on loans and derivatives not designated as hedges | (16) | (9) | (20) |
Fair value losses on designated fair value hedge relationships | - | (9) | (2) |
Net financing charge on defined benefit pension schemes | (9) | (5) | (1) |
Finance costs | (150) | (205) | (323) |
Interest on bank deposits | 1 | 4 | 8 |
Fair value gains on designated fair value hedge relationships | 7 | - | - |
Finance income | 8 | 4 | 8 |
Net finance costs | (142) | (201) | (315) |
2021 | 2022 | 2023 | |
£m | £m | £m | |
Revaluation of investments | 16 | 9 | (11) |
Gain/(loss) on disposal of businesses and assets held for sale | 39 | (18) | (61) |
Net gain/(loss) on disposals and other non-operating items | 55 | (9) | (72) |
2021 | 2022 | 2023 | |
£m | £m | £m | |
Current tax | |||
Current year | (453) | (564) | (652) |
Prior years | 31 | 30 | 77 |
Total current tax charge | (422) | (534) | (575) |
Deferred tax | 96 | 53 | 68 |
Tax expense | (326) | (481) | (507) |
2021 | 2022 | 2023 | ||||
£m | % | £m | % | £m | % | |
Profit before tax | 1,797 | 2,113 | 2,295 | |||
Tax at average applicable rates | (418) | 23.3 % | (498) | 23.6 % | (571) | 24.9 % |
Tax effect of share of results of joint ventures | ||||||
and associates | 6 | (0.3)% | 3 | (0.1)% | 8 | (0.3)% |
Income not taxable and expenses not deductible | 24 | (1.4)% | 21 | (1.0)% | 20 | (0.9)% |
Non-deductible costs of share based | ||||||
remuneration | (2) | 0.1 % | (1) | 0.0 % | (1) | 0.0 % |
Non-deductible disposal-related gains and losses | 1 | (0.1)% | (2) | 0.1 % | (22) | 1.0 % |
Deferred tax assets of the period not recognised | (8) | 0.4 % | (17) | 0.8 % | (3) | 0.1 % |
Change in recognition and measurement of | ||||||
deferred tax | 25 | (1.4)% | 5 | (0.2)% | 4 | (0.2)% |
Movements in provisions and prior year items | 46 | (2.5)% | 8 | (0.4)% | 58 | (2.5)% |
Tax expense | (326) | 18.1 % | (481) | 22.8 % | (507) | 22.1 % |
2021 | 2022 | 2023 | |
£m | £m | £m | |
Tax on items that will not be reclassified to profit or loss | |||
Tax on actuarial movements on defined benefit pension schemes | (48) | (43) | 19 |
Tax on items that may be reclassified to profit or loss | |||
Tax on fair value movements on cash flow hedges | (1) | 8 | (12) |
Net tax (charge)/credit recognised in other comprehensive income | (49) | (35) | 7 |
Tax credit on share based remuneration recognised directly in equity | 12 | - | 24 |
2022 | 2023 | ||
£m | £m | ||
Current tax assets | 15 | 6 | |
Current tax liabilities | (249) | (163) | |
Total | (234) | (157) |
2022 | 2023 | |
£m | £m | |
Deferred tax assets | 146 | 128 |
Deferred tax liabilities | (590) | (473) |
Total | (444) | (345) |
Deferred tax liabilities | Deferred tax assets | ||||||
Acquired | Other | Acquired | Tax losses | Other | |||
intangible | temporary | intangible | carried | Pension | temporary | ||
assets | differences | assets | forward | balances | differences | Total | |
£m | £m | £m | £m | £m | £m | £m | |
Deferred tax (liability)/asset at 1 January | |||||||
2022 | (694) | (196) | 157 | 107 | 68 | 177 | (381) |
Credit/(charge) to profit | 62 | 20 | (30) | (17) | (10) | 28 | 53 |
(Charge)/credit to equity/other | |||||||
comprehensive income | - | (32) | - | - | (10) | 3 | (39) |
Acquisitions | (32) | - | - | 19 | - | - | (13) |
Exchange translation differences | (71) | (23) | 5 | 9 | 1 | 15 | (64) |
Deferred tax (liability)/asset at 1 January | |||||||
2023 | (735) | (231) | 132 | 118 | 49 | 223 | (444) |
Credit/(charge) to profit | 63 | 40 | (31) | (26) | (1) | 23 | 68 |
(Charge)/credit to equity/other | |||||||
comprehensive income | - | (2) | - | - | (1) | 11 | 8 |
Acquisitions | (16) | 1 | - | 9 | - | - | (6) |
Disposals and other | 3 | - | - | - | - | - | 3 |
Exchange translation differences | 33 | 10 | (2) | (5) | – | (10) | 26 |
Deferred tax (liability)/asset at | |||||||
31 December 2023 | (652) | (182) | 99 | 96 | 47 | 247 | (345) |
2022 | 2023 | |||
£m | £m | £m | £m | |
Gross amount | Tax effected | Gross amount | Tax effected | |
Trading losses and temporary differences expiring | ||||
Within 10 years | 123 | 35 | 93 | 26 |
More than 10 years | 1 | - | 14 | 4 |
Available indefinitely | 208 | 58 | 246 | 66 |
Total | 332 | 93 | 353 | 96 |
State and local tax losses expiring | ||||
Within 10 years | 19 | 1 | 21 | 1 |
More than 10 years | 89 | 6 | 63 | 4 |
Available indefinitely | - | - | - | - |
Total | 108 | 7 | 84 | 5 |
Capital losses expiring | ||||
Within 10 years | - | - | - | - |
More than 10 years | - | - | - | - |
Available indefinitely | 22 | 5 | 27 | 7 |
Total | 22 | 5 | 27 | 7 |
EARNINGS PER SHARE – FOR THE |
|||||||||
YEAR ENDED 31 DECEMBER |
2021 |
2022 |
2023 |
||||||
Weighted |
Weighted |
Weighted |
|||||||
Net profit |
average |
Net profit |
average |
Net profit |
average |
||||
attributable to |
number |
attributable to |
number |
attributable to |
number |
||||
shareholders |
of shares |
EPS |
shareholders |
of shares |
EPS |
shareholders |
of shares |
EPS |
|
£m |
(millions) |
(pence) |
£m |
(millions) |
(pence) |
£m |
(millions) |
(pence) |
|
Basic earnings per share |
1,471 |
1,928.0 |
76.3p |
1,634 |
1,918.5 |
85.2p |
1,781 |
1,891.8 |
94.1p |
Diluted earnings per share |
1,471 |
1,939.4 |
75.8p |
1,634 |
1,929.3 |
84.7p |
1,781 |
1,902.8 |
93.6p |
ADJUSTED EARNINGS PER SHARE |
2021 |
2022 |
2023 |
||||||
Adjusted net |
Adjusted net |
Adjusted net |
|||||||
profit |
Weighted |
profit |
Weighted |
profit |
Weighted |
||||
attributable |
average |
attributable |
average |
attributable |
average |
||||
to |
number |
Adjusted |
to |
number |
Adjusted |
to |
number |
Adjusted |
|
shareholders |
of shares |
EPS |
shareholders |
of shares |
EPS |
shareholders |
of shares |
EPS |
|
£m |
(millions) |
(pence) |
£m |
(millions) |
(pence) |
£m |
(millions) |
(pence) |
|
Adjusted earnings per share |
1,689 |
1,928.0 |
87.6p |
1,961 |
1,918.5 |
102.2p |
2,156 |
1,891.8 |
114.0p |
RECONCILIATION OF ADJUSTED NET PROFIT ATTRIBUTABLE TO RELX PLC SHAREHOLDERS |
|||
2021 |
Pre-tax |
Tax on |
|
adjustment |
adjustment |
Total |
|
£m |
£m |
£m |
|
Net profit attributable to shareholders |
1,471 |
||
Adjustments: |
|||
Amortisation of acquired intangible assets |
294 |
22 |
316 |
Other deferred tax credits from intangible assets* |
- |
(61) |
(61) |
Acquisition-related items |
21 |
(11) |
10 |
Net interest on net defined benefit pension obligation |
9 |
(2) |
7 |
Disposals and other non-operating items |
(55) |
1 |
(54) |
Adjusted net profit attributable to shareholders |
1,689 |
||
2022 |
Pre-tax |
Tax on |
|
adjustment |
adjustment |
Total |
|
£m |
£m |
£m |
|
Net profit attributable to shareholders |
1,634 |
||
Adjustments: |
|||
Amortisation of acquired intangible assets |
296 |
30 |
326 |
Other deferred tax credits from intangible assets* |
- |
(64) |
(64) |
Acquisition-related items |
62 |
(13) |
49 |
Net interest on net defined benefit pension obligation |
5 |
(1) |
4 |
Disposals and other non-operating items |
9 |
3 |
12 |
Adjusted net profit attributable to shareholders |
1,961 |
2023 | Pre-tax | Tax on | |
adjustment | adjustment | Total | |
£m | £m | £m | |
Net profit attributable to shareholders | 1,781 | ||
Adjustments: | |||
Amortisation of acquired intangible assets | 280 | 32 | 312 |
Other deferred tax credits from intangible assets* | - | (61) | (61) |
Acquisition-related items | 56 | (8) | 48 |
Net interest on net defined benefit pension obligation | 1 | - | 1 |
Disposals and other non-operating items | 72 | 3 | 75 |
Adjusted net profit attributable to shareholders | 2,156 |
2021 | 2022 | 2023 | ||
RECONCILIATION OF OPERATING PROFIT TO CASH GENERATED FROM OPERATIONS | £m | £m | £m | |
Operating profit | 1,884 | 2,323 | 2,682 | |
Share of results of joint ventures and associates | (29) | (19) | (46) | |
Amortisation of acquired intangible assets | 297 | 294 | 279 | |
Amortisation of internally developed intangible assets | 295 | 309 | 330 | |
Amortisation of pre-publication costs | 60 | 72 | 76 | |
Depreciation of property, plant and equipment | 52 | 47 | 43 | |
Depreciation of right-of-use assets | 80 | 63 | 65 | |
Share based remuneration | 45 | 46 | 56 | |
Total non-cash items | 829 | 831 | 849 | |
Increase in inventories and pre-publication costs | (73) | (103) | (90) | |
Increase in receivables | (103) | (251) | (24) | |
(Decrease)/increase in payables | (32) | 280 | (1) | |
Increase in working capital | (208) | (74) | (115) | |
Cash generated from operations | 2,476 | 3,061 | 3,370 | |
CASH FLOW ON ACQUISITIONS | 2021 | 2022 | 2023 | |
Note | £m | £m | £m | |
Purchase of businesses | 12 | (235) | (373) | (108) |
Deferred payments relating to prior year acquisitions | (19) | (21) | (16) | |
Total | (254) | (394) | (124) |
RECONCILIATION OF NET DEBT | Related | ||||
Cash and | derivative | Finance | |||
cash | financial | lease | |||
equivalents | Debt | instruments | receivable | Total | |
£m | £m | £m | £m | £m | |
As at 1 January 2022 | 113 | (6,167) | 35 | 2 | (6,017) |
Increase in cash and cash equivalents | 208 | - | - | - | 208 |
Decrease in short-term bank loans, overdrafts and | |||||
commercial paper | - | 101 | - | - | 101 |
Issuance of term debt | - | (397) | - | - | (397) |
Repayment of term debt | - | 35 | - | - | 35 |
Repayment of leases | - | 79 | - | (1) | 78 |
Change in net debt resulting from cash flows | 208 | (182) | - | (1) | 25 |
Borrowings in acquired businesses | - | (3) | - | - | (3) |
Remeasurement and derecognition of leases | - | (5) | - | - | (5) |
Inception of leases | - | (34) | - | 5 | (29) |
Fair value and other adjustments to debt and related | |||||
derivatives | - | 230 | (245) | - | (15) |
Exchange translation differences | 13 | (569) | (3) | (1) | (560) |
At 1 January 2023 | 334 | (6,730) | (213) | 5 | (6,604) |
Decrease in cash and cash equivalents | (169) | - | - | - | (169) |
Increase in short-term bank loans, overdrafts and | |||||
commercial paper | - | (84) | - | - | (84) |
Issuance of term debt | - | (651) | - | - | (651) |
Repayment of term debt | - | 847 | - | - | 847 |
Repayment of leases | - | 72 | - | (2) | 70 |
Change in net debt resulting from cash flows | (169) | 184 | - | (2) | 13 |
Borrowings in disposed businesses | - | 1 | - | - | 1 |
Inception of leases | - | (38) | - | 1 | (37) |
Fair value and other adjustments to debt and related | |||||
derivatives | - | (100) | 97 | - | (3) |
Exchange translation differences | (10) | 186 | 8 | - | 184 |
At 31 December 2023 | 155 | (6,497) | (108) | 4 | (6,446) |
Fair value | Fair value | Fair value | |
2021 | 2022 | 2023 | |
£m | £m | £m | |
Goodwill | 131 | 269 | 68 |
Intangible assets | 156 | 125 | 64 |
Property, plant and equipment | 1 | 1 | 1 |
Other non-current assets | - | 3 | - |
Current assets | 4 | 8 | 3 |
Current liabilities | (16) | (21) | (10) |
Borrowings | - | (3) | - |
Deferred tax | (27) | (13) | (6) |
Net assets acquired | 249 | 369 | 120 |
Consideration (after taking account of £4m net cash acquired (2021: £8m; | |||
2022: £6m)) | 249 | 369 | 120 |
Change in consideration deferred to future years and changes in contingent | |||
consideration relating to prior year acquisitions | (14) | 4 | (12) |
Net cash flow | 235 | 373 | 108 |
ORDINARY DIVIDENDS PAID IN THE YEAR | 2021 | 2022 | 2023 |
£m | £m | £m | |
RELX PLC | 920 | 983 | 1,059 |
Total | Total | ||||||||
Total | internally | intangible | |||||||
Software | acquired | developed | assets | ||||||
Market | Customer | Editorial | and | intangible | intangible | excluding | |||
related | related | content | technology | Other | assets | assets | goodwill | ||
Goodwill | £m | £m | £m | £m | £m | £m | £m | £m | |
COST | |||||||||
As at 1 January 2022 | 7,366 | 2,415 | 1,840 | 620 | 740 | 2,350 | 7,965 | 3,511 | 11,476 |
Acquisitions | 269 | 18 | 43 | 27 | 37 | - | 125 | - | 125 |
Additions | - | - | - | - | - | - | - | 402 | 402 |
Disposals and other | - | (2) | (4) | - | - | (9) | (15) | (84) | (99) |
Exchange translation differences | 753 | 268 | 197 | 43 | 68 | 177 | 753 | 291 | 1,044 |
At 1 January 2023 | 8,388 | 2,699 | 2,076 | 690 | 845 | 2,518 | 8,828 | 4,120 | 12,948 |
Acquisitions | 68 | 1 | 28 | 1 | 31 | 3 | 64 | - | 64 |
Additions | - | - | - | - | - | - | - | 447 | 447 |
Disposals and other* | (51) | (28) | (29) | (11) | (4) | (9) | (81) | (59) | (140) |
Exchange translation differences | (382) | (132) | (96) | (22) | (37) | (86) | (373) | (165) | (538) |
At 31 December 2023 | 8,023 | 2,540 | 1,979 | 658 | 835 | 2,426 | 8,438 | 4,343 | 12,781 |
ACCUMULATED AMORTISATION | |||||||||
As at 1 January 2022 | - | 1,438 | 1,132 | 556 | 467 | 2,319 | 5,912 | 2,260 | 8,172 |
Charge for the year | - | 121 | 78 | 29 | 53 | 13 | 294 | 309 | 603 |
Disposals and other | - | (2) | (4) | (5) | 5 | (9) | (15) | (78) | (93) |
Exchange translation differences | - | 161 | 126 | 37 | 47 | 177 | 548 | 194 | 742 |
At 1 January 2023 | - | 1,718 | 1,332 | 617 | 572 | 2,500 | 6,739 | 2,685 | 9,424 |
Charge for the year | - | 116 | 73 | 15 | 63 | 12 | 279 | 330 | 609 |
Disposals and other* | - | (16) | (19) | (5) | (8) | (9) | (57) | (41) | (98) |
Exchange translation differences | - | (87) | (63) | (20) | (27) | (87) | (284) | (108) | (392) |
At 31 December 2023 | - | 1,731 | 1,323 | 607 | 600 | 2,416 | 6,677 | 2,866 | 9,543 |
NET BOOK AMOUNT | |||||||||
At 31 December 2022 | 8,388 | 981 | 744 | 73 | 273 | 18 | 2,089 | 1,435 | 3,524 |
At 31 December 2023 | 8,023 | 809 | 656 | 51 | 235 | 10 | 1,761 | 1,477 | 3,238 |
GOODWILL | 2022 | 2023 |
£m | £m | |
Risk | 4,167 | 3,950 |
Scientific, Technical & Medical | 2,015 | 1,923 |
Legal | 1,572 | 1,524 |
Exhibitions | 634 | 626 |
Total | 8,388 | 8,023 |
KEY ASSUMPTIONS | 2022 | 2023 | ||
Nominal | Nominal | |||
Pre-tax | long-term | Pre-tax | long-term | |
discount | market | discount | market | |
rate | growth rate | rate | growth rate | |
Risk | 11.2% | 4% | 11.3% | 4% |
Scientific, Technical & Medical | 10.5% | 3% | 10.6% | 3% |
Legal | 10.9% | 3% | 10.9% | 4% |
Exhibitions | 13.0% | 4% | 12.3% | 4% |
2022 | 2023 | |
£m | £m | |
Investments in joint ventures and associates | 159 | 178 |
Venture capital investments | 127 | 97 |
Total | 286 | 275 |
2022 | 2023 | |
£m | £m | |
At start of yea r | 105 | 159 |
Share of results of joint ventures and associates | 19 | 46 |
Dividends received from joint ventures and associates | (33) | (21) |
Acquisitions | 62 | - |
Disposals and othe r | 1 | - |
Exchange translation differences | 5 | (6) |
At end of yea r | 159 | 178 |
RELX’s share | ||
2022 | 2023 | |
£m | £m | |
Revenue | 55 | 123 |
Net profit for the year | 19 | 46 |
Total assets | 190 | 200 |
Total liabilities | (75) | (61) |
Net assets | 115 | 139 |
Goodwill | 44 | 39 |
Total | 159 | 178 |
2022 | 2023 | |||||
Land and | Fixtures and | Land and | Fixtures and | |||
buildings | equipment | Total | buildings | equipment | Total | |
£m | £m | £m | £m | £m | £m | |
Cost | ||||||
At start of year | 167 | 516 | 683 | 166 | 452 | 618 |
Acquisitions | 1 | - | 1 | - | 1 | 1 |
Capital expenditure | 3 | 33 | 36 | 5 | 25 | 30 |
Disposals | (19) | (140) | (159) | (30) | (88) | (118) |
Exchange translation differences | 14 | 43 | 57 | (7) | (17) | (24) |
At end of yea r | 166 | 452 | 618 | 134 | 373 | 507 |
Accumulated depreciation | ||||||
At start of year | 111 | 441 | 552 | 115 | 377 | 492 |
Charge for the yea r | 6 | 41 | 47 | 5 | 38 | 43 |
Disposals | (12) | (142) | (154) | (23) | (85) | (108) |
Exchange translation differences | 10 | 37 | 47 | (5) | (14) | (19) |
At end of yea r | 115 | 377 | 492 | 92 | 316 | 408 |
Net book amount | 51 | 75 | 126 | 42 | 57 | 99 |
AT 31 DECEMBER 2022 | Contractual cash flow (including interest) | |||||||
Carrying | Within | More than | ||||||
amount | 1 year | 1-2 years | 2-3 years | 3-4 years | 4-5 years | 5 years | Total | |
£m | £m | £m | £m | £m | £m | £m | £m | |
Borrowings | ||||||||
Fixed rate borrowings | (6,446) | (847) | (1,188) | (772) | (769) | (704) | (3,212) | (7,492) |
Floating rate borrowings | (102) | (102) | - | - | - | - | - | (102) |
Lease liabilities | (182) | (80) | (58) | (36) | (17) | (6) | (34) | (231) |
(6,730) | ||||||||
Derivative financial liabilities | ||||||||
Cash inflows | 835 | 242 | 122 | 8 | - | - | 1,207 | |
Cash outflows | (870) | (262) | (127) | (8) | - | - | (1,267) | |
Forward foreign exchange contracts | (53) | (35) | (20) | (5) | - | - | - | (60) |
Interest rate derivatives | (158) | (48) | (29) | (20) | (18) | (17) | (43) | (175) |
Cross-currency interest rate swaps | (58) | (56) | (31) | (567) | - | - | - | (654) |
(269) | ||||||||
Derivative financial assets | ||||||||
Cash inflows | 665 | 199 | 126 | 24 | 1,014 | |||
Cash outflows | (645) | (192) | (123) | (23) | (983) | |||
Forward foreign exchange contracts | 32 | 20 | 7 | 3 | 1 | - | - | 31 |
Interest rate derivatives | - | 2 | - | - | - | - | - | 2 |
Cross-currency interest rate swaps | – | 29 | 7 | 538 | - | - | - | 574 |
32 | ||||||||
Total | (6,967) | (1,117) | (1,312) | (859) | (803) | (727) | (3,289) | (8,107) |
AT 31 DECEMBER 2023 | Contractual cash flow (including interest) | |||||||
Carrying | Within | More than | ||||||
amount | 1 year | 1-2 years | 2-3 years | 3-4 years | 4-5 years | 5 years | Total | |
£m | £m | £m | £m | £m | £m | £m | £m | |
Borrowings | ||||||||
Fixed rate borrowings | (6,136) | (1,174) | (762) | (764) | (538) | (792) | (3,037) | (7,067) |
Floating rate borrowings | (220) | (220) | – | – | – | – | – | (220) |
Lease liabilities | (141) | (66) | (45) | (17) | (12) | (6) | (28) | (174) |
(6,497) | ||||||||
Derivative financial liabilities | ||||||||
Cash inflows | 621 | 92 | 14 | 3 | – | – | 730 | |
Cash outflows | (632) | (94) | (14) | (3) | – | – | (743) | |
Forward foreign exchange contracts | (16) | (11) | (2) | – | – | – | – | (13) |
Interest rate derivatives | (104) | (35) | (17) | (13) | (13) | (14) | (27) | (119) |
Cross-currency interest rate swaps | (27) | (34) | (539) | – | – | – | – | (573) |
(147) | ||||||||
Derivative financial assets | ||||||||
Cash inflows | 1,149 | 364 | 199 | 30 | – | – | 1,742 | |
Cash outflows | (1,111) | (339) | (186) | (29) | – | – | (1,665) | |
Forward foreign exchange contracts | 62 | 38 | 25 | 13 | 1 | – | – | 77 |
Interest rate derivatives | 19 | – | 4 | 6 | 5 | 4 | 19 | 38 |
Cross-currency interest rate swaps | – | 7 | 527 | – | – | – | – | 534 |
81 | ||||||||
Total | (6,563) | (1,495) | (809) | (775) | (557) | (808) | (3,073) | (7,517) |
2021 | 2022 | 2023 | |
£m | £m | £m | |
Up to one month | 156 | 265 | 259 |
2 to 3 months | 96 | 115 | 130 |
4 to 6 months | 35 | 46 | 56 |
Greater than 6 months | 18 | 23 | 35 |
Total past due | 305 | 449 | 480 |
FAIR VALUE HEDGE RELATIONSHIPS | 31 December | 31 December | ||
2022 | 2023 | |||
Principal | Principal | |||
amount | amount | |||
£m | £m | Fixed rate | Floating rate | |
$700m bond and $700m interest rate swaps maturing 2023 | (579) | - | 3.5% | USD LIBOR+0.8% |
€500m bond and €500m interest rate swaps maturing 2024 | (443) | (433) | 1.0% | Euribor+0.7% |
€600m bond and €600m/$669.3m cross-currency interest rate | ||||
(553) | (524) | 1.3% | USD SOFR+1.5% | |
swaps maturing 2025 | ||||
$200m bond and $200m interest rate swaps maturing 2027 | (165) | - | 7.2% | USD SOFR+6.0% |
$750m bond and $750m interest rate swaps maturing 2030 | (620) | (588) | 3.0% | USD SOFR+1.8% |
€750m bond and €750m interest rate swaps maturing 2031 | - | (650) | 3.8% | Euribor+0.9% |
$500m bond and $500m interest rate swaps maturing 2032 | (413) | (392) | 4.8% | USD SOFR+2.0% |
(2,773) | (2,587) |
GAINS/(LOSSES) ON BORROWINGS AND RELATED DERIVATIVES AND | Fair value | ||||
CARRYING VALUES | 1 January | movement | Exchange | 31 December | Carrying |
2021 | gain/(loss) | gain/(loss) | 2021 | values | |
£m | £m | £m | £m | £m | |
USD debt | (36) | 35 | - | (1) | (1,221) |
Related interest rate swaps | 36 | (28) | - | 8 | 8 |
- | 7 | - | 7 | (1,213) | |
EUR debt | (83) | 55 | 1 | (27) | (940) |
Related interest rate swaps | 83 | (55) | (1) | 27 | 27 |
- | - | - | - | (913) | |
Total relating to USD and EUR debt | (119) | 90 | 1 | (28) | (2,161) |
Total related interest rate swaps | 119 | (83) | (1) | 35 | 35 |
Net gain on borrowings and related | |||||
derivatives/total carrying value | - | 7 | - | 7 | (2,126) |
GAINS/(LOSSES) ON BORROWINGS AND RELATED DERIVATIVES AND | Fair value | |||||
CARRYING VALUES | 1 January | movement | Exchange | 31 December | Carrying | |
2022 | gain/(loss) | gain/(loss) | 2022 | values | ||
£m | £m | £m | £m | £m | ||
USD debt | (1) | 140 | 2 | 141 | (1,630) | |
Related interest rate swaps | 8 | (149) | (2) | (143) | (143) | |
7 | (9) | - | (2) | (1,773) | ||
EUR debt | (27) | 96 | 1 | 70 | (924) | |
Related interest rate swaps | 27 | (96) | (1) | (70) | (70) | |
- | - | - | - | (994) | ||
Total relating to USD and EUR debt | (28) | 236 | 3 | 211 | (2,554) | |
Total related interest rate swaps | 35 | (245) | (3) | (213) | (213) | |
Net gain/(loss) on borrowings and related | ||||||
derivatives/total carrying value | 7 | (9) | - | (2) | (2,767) | |
GAINS/(LOSSES) ON BORROWINGS AND RELATED DERIVATIVES | Fair value | |||||
AND CARRYING VALUES | 1 January | movement | Redemption/ | Exchange | 31 December | Carrying |
2023 | gain/(loss) | close-out | gain/(loss) | 2023 | values | |
£m | £m | £m | £m | £m | £m | |
USD debt | 141 | (22) | (16) | (6) | 97 | (871) |
Related interest rate swaps | (143) | 21 | 16 | 6 | (100) | (100) |
(2) | (1) | - | - | (3) | (971) | |
EUR debt | 70 | (61) | - | (2) | 7 | (1,600) |
Related interest rate swaps | (70) | 60 | - | 2 | (8) | (8) |
- | (1) | - | - | (1) | (1,608) | |
Total relating to USD and EUR debt | 211 | (83) | (16) | (8) | 104 | (2,471) |
Total related interest rate swaps | (213) | 81 | 16 | 8 | (108) | (108) |
Net loss on borrowings and related | ||||||
derivatives/total carrying value | (2) | (2) | - | - | (4) | (2,579) |
Cost of | Foreign | |||
Interest rate | hedging | currency | ||
hedge reserve | reserve | hedge reserve | Total | |
£m | £m | £m | £m | |
Hedge reserve at 31 December 2021: gains/(losses) deferred | 1 | (6) | 29 | 24 |
(Losses)/gains arising in 2022 | (3) | 5 | (20) | (18) |
Amounts recognised in income statement | 1 | - | (18) | (17) |
Exchange translation differences | (1) | - | 1 | - |
Hedge reserve at 31 December 2022: losses deferred | (2) | (1) | (8) | (11) |
Gains/(losses) arising in 2023 | 1 | (3) | 31 | 29 |
Amounts recognised in income statement | 1 | - | 17 | 18 |
Exchange translation differences | - | - | - | - |
Hedge reserve at 31 December 2023: (losses)/gains deferred | - | (4) | 40 | 36 |
Foreign | Principal | ||
currency | amount of | Carrying | |
hedge reserve | hedges | values | |
£m | £m | £m | |
2024 | 16 | 520 | 18 |
2025 | 14 | 482 | 14 |
2026 | 9 | 263 | 9 |
2027 | 1 | 39 | 1 |
Total | 40 | 1,304 | 42 |
2022 | 2023 | |
£m | £m | |
Raw materials | 3 | 1 |
Pre-publication costs | 264 | 278 |
Finished goods | 42 | 39 |
Total | 309 | 318 |
2022 | 2023 | |
£m | £m | |
Trade receivables | 2,193 | 2,144 |
Loss allowance | (118) | (119) |
2,075 | 2,025 | |
Prepayments and accrued income | 310 | 288 |
Current tax receivable | 15 | 6 |
Net finance lease receivable | 5 | 4 |
Total | 2,405 | 2,323 |
2022 | 2023 | |
£m | £m | |
At start of yea r | 106 | 118 |
Charge for the year | 11 | 8 |
Trade receivables written off | (7) | (3) |
Exchange translation differences | 8 | (4) |
At end of year | 118 | 119 |
2022 | 2023 | |
£m | £m | |
Trade payables | 129 | 171 |
Accruals | 844 | 842 |
Social security and other taxes | 159 | 174 |
Other payables | 517 | 487 |
Deferred income | 2,368 | 2,297 |
Total | 4,017 | 3,971 |
2022 | 2023 | |||||
Falling due | Falling due | Falling due | Falling due | |||
within | in more than | within | in more than | |||
1 year | 1 year | Total | 1 year | 1 year | Total | |
£m | £m | £m | £m | £m | £m | |
Financial liabilities measured at amortised cost: | ||||||
Short-term bank loans, overdrafts and commercial pape r | 102 | - | 102 | 220 | - | 220 |
Term debt | - | 3,641 | 3,641 | 606 | 2,940 | 3,546 |
Lease liabilities | 67 | 115 | 182 | 57 | 84 | 141 |
Term debt in fair value hedging relationships | 576 | 1,978 | 2,554 | 430 | 2,041 | 2,471 |
Term debt previously in fair value hedging relationships | 125 | 126 | 251 | - | 119 | 119 |
Total | 870 | 5,860 | 6,730 | 1,313 | 5,184 | 6,497 |
Analysis by year of repayment | ||||||||
2022 | 2023 | |||||||
Short-term | Short-term | |||||||
bank loans, | bank loans, | |||||||
overdrafts | overdrafts | |||||||
and | and | |||||||
commercial | Lease | commercial | Lease | |||||
paper | Term debt | liabilities | Total | paper | Term debt | liabilities | Total | |
£m | £m | £m | £m | £m | £m | £m | £m | |
Within 1 year | 102 | 701 | 67 | 870 | 220 | 1,036 | 57 | 1,313 |
Within 1 to 2 years | - | 1,045 | 24 | 1,069 | - | 620 | 19 | 639 |
Within 2 to 3 years | - | 623 | 25 | 648 | - | 647 | 18 | 665 |
Within 3 to 4 years | - | 660 | 24 | 684 | - | 432 | 17 | 449 |
Within 4 to 5 years | - | 595 | 17 | 612 | - | 689 | 9 | 698 |
After 5 years | - | 2,822 | 25 | 2,847 | - | 2,712 | 21 | 2,733 |
After 1 yea r | - | 5,745 | 115 | 5,860 | - | 5,100 | 84 | 5,184 |
Total | 102 | 6,446 | 182 | 6,730 | 220 | 6,136 | 141 | 6,497 |
Analysis by currency | ||||||||
2022 | 2023 | |||||||
Short-term | Short-term | |||||||
bank loans, | bank loans, | |||||||
overdrafts | overdrafts | |||||||
and | and | |||||||
commercial | Lease | commercial | Lease | |||||
paper | Term debt | liabilities | Total | paper | Term debt | liabilities | Total | |
£m | £m | £m | £m | £m | £m | £m | £m | |
US dolla r | 2 | 3,160 | 65 | 3,227 | 188 | 2,234 | 37 | 2,459 |
Pound sterling | - | - | 40 | 40 | - | - | 29 | 29 |
Euro | - | 3,286 | 57 | 3,343 | 24 | 3,902 | 47 | 3,973 |
Other currencies | 100 | - | 20 | 120 | 8 | - | 28 | 36 |
Total | 102 | 6,446 | 182 | 6,730 | 220 | 6,136 | 141 | 6,497 |
Right-of-use assets |
||
2022 |
2023 |
|
£m |
£m |
|
At start of yea r |
161 |
145 |
Additions |
34 |
38 |
Acquisitions |
3 |
- |
Remeasurement |
8 |
6 |
Disposals |
(8) |
(7) |
Depreciation |
(63) |
(65) |
Exchange translation differences |
10 |
(4) |
At end of year |
145 |
113 |
Lease liability |
||
2022 |
2023 |
|
£m |
£m |
|
Current |
||
Property |
(65) |
(55) |
Non-property |
(2) |
(2) |
Non-current |
||
Property |
(113) |
(82) |
Non-property |
(2) |
(2) |
Total |
(182) |
(141) |
2022 |
2023 |
|
£m |
£m |
|
Net finance lease receivable |
5 |
4 |
RELX PLC |
||||
CALLED UP SHARE CAPITAL – ORDINARY SHARES OF UK 14 ⁵¹/₁₁₆ PENCE EACH ALLOTTED, |
2022 |
2023 |
||
ISSUED AND FULLY PAID |
No. of shares |
£m |
No. of shares |
£m |
At start of year |
1,984,961,632 |
286 |
1,934,880,088 |
279 |
Issue of ordinary shares |
1,918,456 |
- |
3,027,517 |
- |
Cancellation of ordinary shares |
(52,000,000) |
(7) |
(31,000,000) |
(4) |
At end of year |
1,934,880,088 |
279 |
1,906,907,605 |
275 |
NUMBER OF ORDINARY SHARES |
Year ended 31 December |
|||
2022 |
2023 |
|||
Shares in |
Shares in |
|||
issue net of |
issue net of |
|||
treasury |
Shares in |
Treasury |
treasury |
|
shares* |
issue |
shares |
shares* |
|
(millions) |
(millions) |
(millions) |
(millions) |
|
RELX PLC |
||||
At start of year |
1,929.4 |
1,934.9 |
(25.4) |
1,909.5 |
Issue of ordinary shares |
1.9 |
3.0 |
- |
3.0 |
Repurchase of ordinary shares |
(21.7) |
- |
(30.9) |
(30.9) |
Net purchase of shares by the Employee Benefit Trust |
(0.1) |
- (0.1) |
(0.1) |
|
Cancellation of ordinary shares |
- |
(31.0) |
31.0 |
- |
At end of year |
1,909.5 |
1,906.9 |
(25.4) |
1,881.5 |
Translation |
Hedge |
Other |
|||
Total |
reserve |
reserve |
reserves |
Total |
|
2022 |
2023 |
2023 |
2023 |
2023 |
|
£m |
£m |
£m |
£m |
£m |
|
At start of year |
2,331 |
677 |
(8) |
1,725 |
2,394 |
Profit attributable to shareholders |
1,634 |
- |
- |
1,781 |
1,781 |
Dividends paid |
(983) |
- |
- |
(1,059) |
(1,059) |
Actuarial gains on defined benefit pension schemes |
164 |
- |
- |
(75) |
(75) |
Fair value movements on cash flow hedges |
(18) |
- |
29 |
- |
29 |
Transfer to profit from cash flow hedge reserve |
(17) |
- |
18 |
- |
18 |
Tax recognised in other comprehensive income |
(35) |
- |
(12) |
19 |
7 |
Exchange differences on translation of foreign operations |
427 |
(285) |
- |
– |
(285) |
Cancellation of shares |
(1,120) |
- |
- |
(673) |
(673) |
Increase in share based remuneration reserve (including tax) |
47 |
- |
- |
77 |
77 |
Settlement of share awards |
(35) |
- |
- |
(34) |
(34) |
Disposal of non ‐ controlling interests |
(1) |
- |
- |
- |
- |
At end of year |
2,394 |
392 |
27 |
1,761 |
2,180 |
KEY MANAGEMENT PERSONNEL REMUNERATION |
2021 |
2022 |
2023 |
||||
£m |
£m |
£m |
|||||
Salaries, other short-term employee benefits and non-executive fees |
7 |
7 |
8 |
||||
Post-employment benefits |
1 |
- |
- |
||||
Share based remuneration* |
8 |
7 |
14 |
||||
Total |
16 |
14 |
22 |
||||
EXECUTIVE DIRECTORS |
Annual |
Share based |
|||||
Salary |
Benefits |
incentive |
remuneration* |
Pension* |
Total |
||
£’000 |
£’000 |
£’000 |
£’000 |
£’000 |
£’000 |
||
Total Executive Directors |
2021 |
2,085 |
97 |
3,604 |
7,953 |
774 |
14,513 |
2022 |
2,137 |
97 |
3,251 |
6,857 |
268 |
12,610 |
|
2023 |
2,190 |
97 |
3,808 |
14,354 |
241 |
20,690 |
2021 |
2022 |
2023 |
|
NON-EXECUTIVE DIRECTORS |
£’000 |
£’000 |
£’000 |
Fees and benefits |
1,598 |
1,566 |
1,566 |
Statement of |
|||||
Income statement |
financial position |
||||
2021 |
2022 |
2023 |
2022 |
2023 |
|
Euro to sterling |
1.16 |
1.17 |
1.15 |
1.13 |
1.15 |
US dollar to sterling |
1.38 |
1.24 |
1.24 |
1.21 |
1.28 |
Share |
Reg |
|
Company name |
class |
office |
Australia |
||
Agricultural Insights Pty Ltd |
Ordinary |
AUS1 |
LNRS Data Services (Australia) Pty Ltd |
Ordinary |
AUS1 |
Reed Exhibitions Australia Pty Limited |
Ordinary |
AUS2 |
RELX Holdings Australia Pty Ltd |
Ordinary |
AUS2 |
RELX Trading Australia Pty Limited |
Ordinary |
AUS2 |
Austria |
||
LexisNexis Verlag ARD ORAC GmbH & Co KG |
Partnership Interest |
AUT2 |
ORAC GmbH |
Ordinary |
AUT2 |
RELX Austria GmbH |
Ordinary |
AUT3 |
RX CEE GmbH |
Ordinary |
AUT1 |
RX Salzburg GmbH |
Ordinary |
AUT3 |
RX Wien GmbH |
Ordinary |
AUT1 |
Standout GmbH |
Ordinary |
AUT4 |
Belgium |
||
LexisNexis BV |
Ordinary |
BEL1 |
Brazil |
||
Elsevier Editora Limiteda |
Quotas |
BRA1 |
Fircosoft Brasil Consultoria e Servicos de Informatica Ltda |
Quotas |
BRA2 |
Gestora de Inteligencia de Credito S.A. (20%) |
Common, Preferred |
BRA8 |
LexisNexis Informacoes e Sistemas Empresariais Limiteda |
Quotas |
BRA6 |
LexisNexis Servicos de Analise de Risco Limiteda |
Quotas |
BRA7 |
MLex Brasil Midia Mercadologica Limiteda |
Quotas |
BRA4 |
Reed Exhibitions Alcantara Machado Limiteda |
Quotas |
BRA3 |
SST Software do Brasil Limiteda |
Quotas |
BRA5 |
Canada |
||
Corps Events IntCan |
Class A Voting |
CAN3 |
Elsevier Canada Inc. |
Common |
CAN2 |
Human API Technologies Inc. |
Voting |
CAN4 |
LexisNexis Canada Inc. |
Class B |
CAN1 |
PCLaw Time Matters Canada Inc. |
Common |
CAN5 |
RELX Canada Limited |
Common |
CAN1 |
China |
||
Bakery China Exhibitions Co., Limited (25%) |
Ordinary |
CHN1 |
Beijing Medtime Elsevier Education Technology Co., Limited |
Common |
CHN2 |
(49%) |
||
Beijing Reed Elsevier Science and Technology Co Ltd 1 |
Common |
CHN20 |
C-One Energy (Guangzhou) Co., Limited |
Ordinary |
CHN5 |
Jingxunlingsi (Beijing) Information Technology Co Ltd 1 |
Ordinary |
CHN4 |
KeAi Communications Co., Limited (49%) |
Ordinary |
CHN15 |
LexisNexis Information Technology Co. Limited |
Ordinary |
CHN4 |
LexisNexis Risk Solutions (Shanghai) Information |
Common |
CHN7 |
Technologies Co. Limited |
||
LNRS Data Services (Shanghai) Co Limited |
Ordinary |
CHN13 |
Peili Computer Co Ltd 1 |
Ordinary |
CHN13 |
Reed Elsevier Information Technology (Beijing) Co., Limited |
Common |
CHN3 |
Reed Exhibitions (China) Co., Limited |
Ordinary |
CHN4 |
Reed Exhibitions (Shanghai) Co., Limited |
Ordinary |
CHN10 |
Reed Exhibitions Hengjin Co., Limited (51%) |
Ordinary |
CHN12 |
Reed Exhibitions Kuozhan (Shanghai) Co., Limited (60%) |
Ordinary |
CHN8 |
Reed Huabai Exhibitions (Beijing) Co., Limited (51%) |
Ordinary |
CHN4 |
Reed Huabo Exhibitions (Shenzhen) Co., Limited (65%) |
Ordinary |
CHN16 |
Reed Huaqun Exhibitions Co., Limited (52%) |
Ordinary |
CHN4 |
Reed Sinopharm Exhibitions Co., Limited (50%) |
Ordinary |
CHN4 |
RX (China) Investment Co., Limited |
Ordinary |
CHN9 |
RX (Shenzhen) Co., Limited |
Ordinary |
CHN6 |
RX Huabo (Shenzhen) Technology Co. Limited 1 |
Ordinary |
CHN19 |
RX Technology (Shanghai) Co. Limited 1 |
Ordinary |
CHN18 |
Shanghai Datong Medical Information Technology Co., |
Ordinary |
CHN17 |
Limited |
||
Shanghai SinoReal Exhibitions Co., Limited (27.5%) |
Ordinary |
CHN11 |
Z&R Exhibitions Co., Limited (27.5%) |
Ordinary |
CHN14 |
Colombia |
||
LexisNexis Risk Solutions SAS |
Ordinary |
COL1 |
Denmark |
||
Elsevier A/S |
Ordinary |
DNK1 |
Egypt |
||
Elsevier Egypt LLC |
Ordinary |
EGY1 |
Share |
Reg |
|
Company name |
class |
office |
France |
||
Case Law Analytics SAS |
Ordinary |
FRA9 |
Closd SAS |
Ordinary |
FRA8 |
Corp Events SARL |
Ordinary |
FRA3 |
Elsevier Holding France SAS |
Ordinary |
FRA1 |
Elsevier Masson SAS |
Ordinary |
FRA1 |
Fircosoft SAS |
Ordinary |
FRA7 |
GIE EDI Data (83%) |
Ordinary |
FRA2 |
GIE Juris Data |
Ordinary |
FRA2 |
Jarvis SAS |
Ordinary |
FRA10 |
LexisNexis Business Information Solutions SA |
Ordinary |
FRA2 |
LexisNexis Business Information Solutions Holding SA |
Ordinary |
FRA4 |
LexisNexis International Development & Services SAS |
Ordinary |
FRA2 |
LexisNexis SA |
Ordinary |
FRA2 |
Reed Exhibitions ISG SARL |
Ordinary |
FRA5 |
RELX France SA |
Ordinary |
FRA3 |
RELX France Services SAS |
Ordinary |
FRA7 |
RX France SAS |
Ordinary |
FRA3 |
SAFI SA (50%) |
Ordinary |
FRA6 |
Germany |
||
Elsevier GmbH |
Ordinary |
DEU3 |
Elsevier Information Systems GmbH |
Ordinary |
DEU2 |
IPlytics GmbH |
Ordinary |
DEU7 |
LexisNexis GmbH |
Ordinary |
DEU4 |
PatentSight GmbH |
Ordinary |
DEU6 |
RELX Deutschland GmbH |
Ordinary |
DEU1 |
RX Deutschland GmbH |
Ordinary |
DEU1 |
Tschach Solutions GmbH |
Ordinary |
DEU5 |
Hong Kong |
||
Ascend China Holding Limited |
Ordinary |
HNK4 |
JC Exhibition and Promotion Limited (65%) |
Ordinary |
HNK4 |
JYLN Sager Limited |
Ordinary |
HNK2 |
LNRS Data Services (China) Limited |
Ordinary |
HNK1 |
Reed Exhibitions Limited |
Ordinary |
HNK4 |
RELX (Greater China) Limited |
Ordinary |
HNK3 |
India |
||
FircoSoft India Private Limited (Liquidation in progress) |
Ordinary |
IND2 |
Reed Elsevier Publishing (India) Private Limited |
Ordinary |
IND1 |
Reed Manch Exhibitions Private Limited |
Ordinary |
IND1 |
Reed Triune Exhibitions Private Limited (72%) |
Ordinary |
IND3 |
RELX India Private Limited |
Ordinary |
IND1 |
Indonesia |
||
PT Reed Exhibitions Indonesia (70%) |
Class A Preferred |
IDN1 |
Class B Common |
||
PT RELX Information Analytics Indonesia |
Ordinary |
IDN2 |
Irish Republic |
||
Elsevier (Ireland) Limited |
Ordinary |
IRL2 |
LexisNexis Risk Solutions (Europe) Limited |
Ordinary |
IRL1 |
RELX International Finance Designated Activity Company |
Ordinary |
IRL1 |
Israel |
||
LexisNexis Israel Ltd |
Ordinary |
ISR1 |
Italy |
||
Elsevier SRL |
Registered Capital |
ITA1 |
ICIS Italia SRL |
Ordinary |
ITA2 |
RX Italy SRL |
Ordinary |
ITA1 |
Japan |
||
Elsevier Japan KK |
Ordinary |
JPN1 |
LexisNexis Japan KK |
Ordinary |
JPN2 |
PatentSight Japan Inc. |
Common |
JPN2 |
RX Japan Ltd |
Ordinary |
JPN2 |
Share | Reg | |
Company name | class | office |
Korea (Republic of) | ||
Elsevier Korea LLC | Ordinary | KOR1 |
LexisNexis Legal and Professional Service Korea Limited | Ordinary | KOR2 |
Reed Exhibitions Korea Limited | Ordinary | KOR3 |
Reed Exporum Limited (60%) | Ordinary | KOR4 |
Reed K. Fairs Limited (70%) | Ordinary | KOR3 |
Macau | ||
Reed Exhibitions Macau Limited | Ordinary | MAC1 |
Malaysia | ||
LexisNexis Malaysia Sdn Bhd | Ordinary | MYS1 |
Mexico | ||
Human API Technologies, S. de R.L. de C.V. | Fixed | MEX3 |
Masson-Doyma Mexico, S.A. | Ordinary | MEX1 |
Reed Exhibitions Mexico S.A. de C.V. | Fixed | MEX2 |
Netherlands | ||
AGRM Solutions C.V. | Partnership Interest | NLD1 |
Caselex B.V. | Ordinary | NLD1 |
Elsevier B.V. | Ordinary | NLD1 |
ICIS Benchmarking Europe B.V. | Ordinary | NLD1 |
LexisNexis Business Information Solutions B.V. | Ordinary | NLD1 |
LNRS Data Services B.V. | Ordinary | NLD1 |
Misset Uitgeverij B.V. (49%) | Ordinary | NLD2 |
RELX Employment Company B.V. | Ordinary | NLD1 |
RELX Finance B.V. | Ordinary | NLD1 |
RELX Holdings B.V. | Ordinary | NLD1 |
RELX Nederland B.V. | Ordinary | NLD1 |
RELX Overseas B.V. | Ordinary RE | NLD1 |
New Zealand | ||
LexisNexis NZ Limited | Ordinary | NZL1 |
Philippines | ||
Reed Elsevier Shared Services (Philippines) Inc. | Common | PHL1 |
Poland | ||
AI Digital Contracts Sp. z.o.o. (75%) | Ordinary | POL1 |
Elsevier Sp. z.o.o. | Ordinary | POL2 |
Russia | ||
Elsevier LLC (Liquidation in progress) | Participation Shares | RUS1 |
LexisNexis LLC (Liquidation in progress) | Participation Shares | RUS2 |
Singapore | ||
Elsevier (Singapore) Pte Limited | Ordinary | SGP1 |
LexisNexis Philippines Pte Limited | Ordinary-B, Preference SGP2 | |
LNRS Data Services Pte Limited | Ordinary | SGP1 |
RE (HAPL) Pte Limited | Ordinary | SGP1 |
RELX (Singapore) Pte Limited | Ordinary | SGP2 |
South Africa | ||
Globalrange SA (Pty) Ltd | Ordinary | ZAF1 |
LexisNexis (Pty) Limited (78%) | Ordinary | ZAF2 |
LexisNexis Risk Management (Pty) Limited (78%) | Ordinary | ZAF2 |
LexisNexis South Africa Shared Services (Pty) Limited | Ordinary | ZAF2 |
Reed Events Management (Pty) Limited (90%) | Ordinary | ZAF2 |
Reed Exhibitions (Pty) Limited (90%) | Ordinary | ZAF2 |
Reed Exhibitions Group (Pty) Limited (90%) | Ordinary | ZAF2 |
Reed Venue Management (Pty) Limited (90%) | Ordinary | ZAF2 |
RELX (Pty) Limited | Ordinary | ZAF2 |
Spain | ||
Elsevier Espana S.L.U | Participations | ESP1 |
Share | Reg | |
Company name | class | office |
Sweden | ||
Behaviometrics AB | Ordinary | SWE1 |
Taiwan | ||
Elsevier Taiwan LLC | Ordinary | TWN1 |
Thailand | ||
Reed Tradex Company Limited (49%) | Ordinary, Preference | THA1 |
RELX Holding (Thailand) Co., Limited | Ordinary | THA2 |
RELX Information Analytics (Thailand) Co., Limited | Ordinary | THA3 |
Turkey | ||
Elsevier STM Bilgi Hizmetleri Limited Sirketi | Ordinary | TUR1 |
Mack Brooks Fuarcilik A.S. | Registered Capital | TUR2 |
Reed Tuyap Fuarcilik A.S. (50%) | A Ordinary, B Ordinary | TUR3 |
United Arab Emirates | ||
Reed Exhibitions FZ-LLC | Ordinary | UAE1 |
RELX Middle East FZ-LLC | Ordinary | UAE2 |
United Kingdom | ||
Agricultural Insights Ltd | Ordinary | GBR2 |
Aistemos Limited | Ordinary | GBR4 |
Butterworths Limited | Ordinary | GBR4 |
Cordery Compliance Limited (71%) | Ordinary | GBR4 |
Cordery Limited (71%) | Ordinary | GBR4 |
Crediva Limited | Ordinary | GBR5 |
Digital Foundry Network Limited (50%) | Ordinary | GBR3 |
Elsevier Limited | Ordinary | GBR6 |
Emailage Limited (Liquidation in progress) | Ordinary | GBR5 |
Gamer Network Limited | Ordinary | GBR3 |
Hookshot Media Ltd (23.5%) | Ordinary | GBR7 |
Interfolio UK Ltd | Ordinary | GBR8 |
LexisNexis Risk Solutions UK Limited | Ordinary | GBR5 |
LNRS Data Services Holdings Limited | Ordinary | GBR1 |
LNRS Data Services Limited | Ordinary | GBR2 |
Mack-Brooks Exhibitions Limited | Ordinary | GBR3 |
MCM Expo Ltd (Liquidation in progress) | Ordinary | GBR3 |
MLex Limited | Ordinary | GBR4 |
Offshore Europe (Management) Limited | Ordinary | GBR3 |
Offshore Europe Partnership (50%) | Partnership Interest | GBR3 |
Out There Gaming Limited (70%) | Ordinary | GBR3 |
RE (HPL) Limited | Ordinary | GBR1 |
RE (RCB) Limited | Ordinary | GBR1 |
RE Secretaries Limited | Ordinary | GBR1 |
RE (SOE) Limited | Ordinary | GBR3 |
Reed Events Limited | Ordinary | GBR3 |
Reed Exhibitions Limited | Ordinary | GBR3 |
Reed Nominees Limited | Ordinary | GBR1 |
RELX Finance Limited | Ordinary | GBR1 |
RELX Group plc* | Ordinary | GBR1 |
RELX (Holdings) Limited | Ordinary | GBR1 |
RELX (Investments) plc | Ordinary | GBR1 |
RELX Overseas Holdings Limited | Ordinary | GBR1 |
RELX (UK) Limited | Ordinary | GBR1 |
REV GP (UK) LLP (50%) | Membership Interest | GBR1 |
REV Venture Partners Limited | Ordinary | GBR1 |
REV V LP | Partnership Interest | GBR1 |
SciBite Limited | Ordinary | GBR8 |
Tracesmart Limited | Ordinary | GBR5 |
TruNarrative Ltd (Liquidation in progress) | Ordinary | GBR5 |
Share | Reg | |
Company name | class | office |
United States | ||
Accuity Asset Verification Services Inc. | Common Stock | USA1 |
Accuity Inc. | Common Stock | USA1 |
Agricultural Insights LLC | Membership Interest USA1 | |
American Textile Machinery Exhibition-International, | Common Stock | USA2 |
Inc. (40%) | ||
Aries Systems Corporation | Common Stock | USA2 |
Dunlap-Hanna Publishers (50%) | Partnership Interest | USA2 |
Elsevier Holdings Inc. | Common Stock | USA2 |
Elsevier Inc. | Common Stock | USA2 |
Elsevier STM Inc. | Common Stock | USA2 |
Emailage Corporation | Common Stock | USA1 |
Enclarity, Inc. | Common Stock | USA1 |
Gaming Business Asia, LLC (50%) | Membership Interest USA2 | |
Health Market Science, Inc. | Common Stock | USA1 |
HumanAPI Inc. | Common Stock | USA1 |
ID Analytics, LLC | Membership Interest USA1 | |
Interfolio, Inc. | Common Stock | USA2 |
Interfolio Data 180, LLC | Membership Interest USA2 | |
Jarvis Software LLC | Membership Interest USA2 | |
Knovel Corporation | Common Stock | USA2 |
Knowable Inc (75%) | Common Stock | USA2 |
Legal InQuery Solutions Inc. | Common Stock | USA5 |
LexisNexis Claims Solutions Inc. | Common Stock | USA1 |
LexisNexis Coplogic Solutions Inc. | Common Stock | USA1 |
LexisNexis of Puerto Rico, Inc. | Common Stock | USA7 |
LexisNexis Risk Data Management, LLC | Membership Interest USA1 | |
LexisNexis Risk Holdings Inc. | Common Stock | USA1 |
LexisNexis Risk Solutions Inc. | Common Stock | USA1 |
LexisNexis Risk Solutions FL Inc. | Common Stock | USA1 |
LexisNexis Special Services Inc. | Common Stock | USA4 |
LexisNexis VitalChek Network Inc. | Common Stock | USA1 |
LNRS Data Services Inc. | Common Stock | USA1 |
Matthew Bender & Company, Inc. | Common Stock | USA2 |
MLex US, Inc. | Common Stock | USA2 |
PCLaw Time Matters LLC (51%) | Membership Interest USA2 | |
Portfolio Media, Inc. | Common Stock | USA2 |
Reed Technology and Information Services LLC | Membership Interest USA2 | |
RELX Capital Inc. | Common Stock | USA3 |
RELX Inc. | Common Stock | USA2 |
RELX Risks Inc. | Common Stock | USA6 |
REV IV Partnership LP | Partnership Interest | USA3 |
SAFI Americas LLC (50%) | Membership Interest USA2 | |
SageStream, LLC | Membership Interest USA1 | |
The Reed Elsevier Ventures 2011 Partnership LP | Partnership Interest | USA3 |
The Reed Elsevier Ventures 2013 Partnership LP | Partnership Interest | USA3 |
The Remick Publishers (50%) | Partnership Interest | USA2 |
ThreatMetrix, Inc. | Common Stock | USA1 |
World Compliance, Inc. | Common Stock | USA1 |
Vietnam | ||
Reed Tradex Vietnam LLC (49%) | Membership Interest | VIE1 |
Registered offices | ||
Australia | ||
AUS1: | Building B, Level 2, Unit 11, 1 Maitland Place, Baulkham Hills, NSW 2153 | |
AUS2: | Tower 2, Level 1, 475 Victoria Avenue, Chatswood NSW 2067 | |
Austria | ||
AUT1: | Messeplatz 1, 1020, Vienna | |
AUT2: | Trabrennstrasse 2A,1020, Vienna | |
AUT3: | Am Messezentrum 6, 5021, Salzburg | |
AUT4: | Am Messezentrum 7, 5020, Salzburg | |
Belgium | ||
BEL1: | Oudenaardseheerweg 129, 9810 Nazareth | |
Brazil | ||
BRA1: | Av. Almirante Barroso 81, Sala 33A114, 20031-004 Centro, Rio de Janeiro | |
BRA2: | Rua Bela Cintra, 1200, Andar 6 Conj 61 A 64, Consolacao, Sao Paulo, 01415-002 | |
BRA3: | Rua Bela Cintra no. 1200, 10th floor, Sao Paulo, 01415-002 | |
BRA4: | Avenida Paulista 2300, Andar Pilotis, Sao Paulo, SP 01 310-300 | |
BRA5: | Rua Coronel Fonseca, 203A – Centro Botucatu, Sao Paulo, 18600-200 | |
BRA6: | Rua Funchal, 538, 4º Andar, Conj. 42, Salas 4, 5 e 6, Vila Olímpia, Sao Paulo, | |
04551-060 | ||
BRA7: | Alameda Rio Negro, 161 Alphaville Industrial, Barueri, Sao Paulo 06.454-000 | |
BRA8: | Alameda Araguaia, Alphaville, Conjuntos 81-84, Centro Empresarial Araguaia, | |
Barueri, Sao Paulo | ||
2104, 8-9 Andar | ||
Canada | ||
CAN1: | 111 Gordon Baker Road, Suite 900, Toronto, Ontario, M2H 3R1 | |
CAN2: | 26E-1501 av. McGill College, Montreal, Quebec, H3A 3N9 | |
CAN3: | 555 Richmond Street West, Suite 405, Toronto ON M5V 3B1 | |
CAN4: | 20th Floor, 250 Howe Street, Vancouver BC, V6C 3R8 | |
CAN5: | 199 Bay Street, 4000, Toronto, Ontario, M5L 1A9 | |
China | ||
CHN1: | Zhongkun Building, Room 612, Gaoliangqiaoxie Street, No. 59, Haidan District, | |
Beijing, 100044 | ||
CHN2: | Room 516, 5th Floor, Building 22, Area 11, No. 38, Xueyuan Road, Haidian | |
District, Beijing | ||
CHN3: | Oriental Plaza, No. 1 East Chang An Ave, Tower W1, 7th Floor, Unit 1-7, Dong | |
Cheng District, Beijing, 100738 | ||
CHN4: | Ping An International Finance Centre, Room 1504-1505, 15th Floor, Tower A- | |
101, 3-24 Floor, Xinyuan South Road, Chaoyang District, Beijing, 100027 | ||
CHN5: | Unit B1303-1 & 1305, 13F Center Plaza, 161 Linhe Road West, Tianhe District | |
Guangzhou | ||
CHN6: | Unit 303, 3F, Tower 3 Kerry Plaza ,No.1 Zhong Xin Si Road, Fu Tian District, | |
Shenzhen | ||
CHN7: | Unit A-1, 5th Floor, No. 567, Tianshan West Road, Changning District, | |
Shanghai | ||
CHN8: | Intercontinental Center, 42F, 100 Yutong Road, Zhabei District, Shanghai, | |
200070 | ||
CHN9: | Room 319, 238 Jiangchangsan Road, Jing’an District, Shanghai | |
CHN10: | Room 304, Sanlian Building, No.8, Huajing Road, Pudong District, Shanghai, | |
200070 | ||
CHN11: | Building 2, Room No. 3895, Changjiang Avenue, No. 161, Changliang Farm, | |
Chongming County, Shanghai | ||
CHN12: | Floor 2, No.979, Yunhan Road, Nicheng Town, Pudong New District, Shanghai, | |
200000 | ||
CHN13: | 4/F Block 3, No 999 Jingzhong Road, Changning District, Shanghai | |
CHN14: | A0208, 1st Floor, Building 2, Yard 66, Yanfu Road, Yancun Tow, Fangshan | |
District, Beijing | ||
CHN15: | 16 Donghuangchenggen North Street, Beijing, 100717 | |
CHN16: | Shenzhen International Chamber of Commerce Tower, Room 1801-1802, 1805, | |
Fuhua 3rd Road, Futian District, Shenzhen, 518048 | ||
CHN17: | 5/F Unit A, Digital China Centre No. 567 Tianshan West Road, ChangNing | |
District, Shanghai, 200335 | ||
CHN18: | Room 726, 1256-1258 Wan Rong Road, Jing An District, Shanghai | |
CHN19: | Room 1801, 168 Fuhua No. 3 Road , Fu Tian District, Shenzhen | |
CHN20: | Oriental Plaza, No. 1 East Chang An Ave, Tower W1, 7th Floor, Unit 12C, Dong | |
Cheng District, Beijing, 100738 | ||
Colombia | ||
COL1: | Philippe Prietocarrizosa & Uria Abogados, Carrera 9 No. 74-08 Oficina 105, | |
Bogota, d.c., 76600 | ||
Denmark | ||
DNK1: | Niels Jernes Vej 10, 9220, Aalborg East | |
Egypt | ||
EGY1: | Land Mark Office Building, 2nd Floor, 90th Street, City Center, 5th Settlement, | |
New Cairo, Cairo |
Registered offices | |
France | |
FRA1: | 65 rue Camille Desmoulins, 92130, Issy les Moulineaux |
FRA2: | 141 rue de Javel, 75015, Paris |
FRA3: | 52 Quai de Dion Bouton, 92800, Puteaux |
FRA4: | Immeuble Technopolis, 350 rue Georges Besse, 30000, Nimes |
FRA5: | 27 Quai Alphonse Le Gallo, 92100, Boulogne-Billancourt |
FRA6: | 6-8 rue Chaptal, 75009, Paris |
FRA7: | Immeuble Vivacity, 151-155 rue de Bercy, 75012, Paris |
FRA8: | 168 rue Saint-Denis, 75002, Paris |
FRA9: | 10 bis, quai Turenne, 44000, Nantes |
FRA10: | 9 rue du Quatre-Septembre, 75002, Paris |
Germany | |
DEU1: | Volklinger Strasse 4, 40219, Dusseldorf |
DEU2: | St. Martin Tower, Wing, 2nd floor, Franklinstrasse 61-63, 60486, |
Frankfurt am Main Hessen | |
DEU3: | Bernhard-Wicki-Strasse 5, 80636, Munich |
DEU4: | Heerdter Sandberg 30, 40549, Dusseldorf |
DEU5: | Stephanienstrasse 86, 76133 Karlsruhe |
DEU6: | Joseph-Schumpeter-Allee 33, 53227, Bonn |
DEU7: | Ohlauer Str. 43, Aufgang C, c/o Thunderbolt Collective, 10999, Berlin |
Hong Kong | |
HNK1: | 5/F, Manulife Place, 348 Kwun Tong Road, Kowloon |
HNK2: | Flat 1506, 15/F, Lucky Center, No. 165-171 Wan Chai Road, Wan Chai |
HNK3: | 11/F Oxford House, Taikoo Place, 979 King’s Road, Quarry Bay |
HNK4: | 17th Floor, One Island East, Taikoo Place, 18 Westlands Road, Quarry |
Bay | |
India | |
IND1: | 818, 8th Floor, Indraprakash Building, 21 Barakhamba Road, New |
Delhi, Delhi, 110001 | |
IND2: | Ascendas International Tech Park, Crest Building 12th Floor, Taramani |
Road, Taramani, Chennai, 600113 | |
IND3: | 25, 3rd floor, 8th Main Road, Vasanth Nagar, Bangalore, Karnataka, |
560052 | |
Indonesia | |
IDN1: | APL Tower Central Park 26th Floor Unit T3 Jl. S. Parman Kav., 28, |
Grogol, Pertamburan Jakarta Barat 11470 | |
IDN2: | Gedung World Trade Center, 3 LT 20 Spaces JL Jend Sudirman Kav 29- |
31 RT/RW 008/003, Karet Kuningan, Setiabudi, Jakarta Selatan, DKI | |
Jakarta 12940 | |
Irish Republic | |
IRL1: | Riverside One, Sir John Rogerson’s Quay, Dublin 2, DO2 X576 |
IRL2: | 1F Cedarhurst Building, Arkle Road, Sandyford Business Park, Dublin, |
D18 X6N2 | |
Israel | |
ISR1: | Meitar, Attorneys at Law, 16 Abba Hillel Road, Ramat Gan 5250608 |
Italy | |
ITA1: | Via Marostica 1, 20146, Milan |
ITA2: | Studio Colombo e Associati, Via San Damiano 9, 20122, Milan |
Japan | |
JPN1: | 1-9-15 Higashi-Azabu, Minato-Ku, Tokyo, 106-044 |
JPN2: | 11F, Yaesu Central Tower, Tokyo Midtown Yaesu, 2-2-1 Yaesu Chuo-ku, |
Tokyo 104-0028 | |
Korea (Republic of) | |
KOR1: | Chunwoo Building, 4th floor, 534 Itaewon-dong, Yongsan-gu, Seoul, |
140-861 | |
KOR2: | 206 Noksapyeong-daero, Yongsan-gu, Seoul, 140-861 |
KOR3: | 1622-24 Block A Terra Tower 2, 201 Songpa-daero, Songpa-gu, Seoul |
KOR4: | 4th floor at 195-6 Jamsil-dong, Songpagu, Seoul |
Macau | |
MAC1: | Rua De Xangai, No. 175 Edif. Associacao Comercial de Macau, 11 |
Andar, Bloco K |
Registered offices | |
Malaysia | |
MYS1: | Suite 29-1, Level 29, Vertical Corporate, Tower B, Avenue 10, The |
Vertical, 59200 Bangsar South City, Kuala Lumpur | |
Mexico | |
MEX1: | Masson-Doyma Mexico S.A., Av Insurgentes Sur 1388 Piso 8, Col Actipan |
Mixcoac Del. Benito Juarez, Mexico DF, CP 03230 | |
MEX2: | Avenida Paseo de la Reforma 243, Piso 15, Col. Cuauhtemoc, Mexico |
City, 06500 | |
MEX3: | Av. Miguel Hidalgo y Costilla, 1995 piso 6 oficina 10 , Guadalajara, |
Jalisco, 46600 | |
Netherlands | |
NLD1: | Radarweg 29, 1043 NX Amsterdam |
NLD2: | Hanzestraat 1, 7006RH Doetinchem |
New Zealand | |
NZL1: | Level 1, 138 The Terrace, P.O. Box 472, Wellington 6011 |
Philippines | |
PHL1: | Building H, 2nd Floor, U.P. Ayalaland TechnoHub, Commonwealth |
Avenue, Quezon City, Metro Manila, 1101 | |
Poland | |
POL1: | Plac Grunwaldzki 23-27, 50-365 Wroclaw |
POL2: | Al. JJana Pawla II, 22, 00-133, Warszawa |
Russia | |
RUS1: | Building 1, Facility 1, Room 80, 9/26 Shchipok St., Municipal District |
Zamoskvorechye, 115054, Moscow | |
RUS2: | Building 1, Facility 1, Room 5, 9/26 Shchipok St., Municipal District |
Zamoskvorechye, 115054, Moscow | |
Singapore | |
SGP1: | 3 Killiney Road, #08-01 Winsland House 1, 239519 |
SGP2: | 80 Robinson Road, #02-00, 068898 |
South Africa | |
ZAF1: | Ground Floor Pebble Beach Building, Fourways Golf Park, 32 Roos |
Street, Sandton, 2191 | |
ZAF2: | Building 8, Country Club Estate Office Park, 21 Woodlands Drive, |
Woodmead, Gauteng, 2191 | |
Spain | |
ESP1: | C/ Josep Tarradellas 20-30, 1º / 20029, Barcelona |
Sweden | |
SWE1: | Aurorum 8, 977 75 Lulea |
Taiwan | |
TWN1: | 9F., No. 96, Sec. 2, Zhongshan N. Rd., Zhongshan Dist, Taipei, 10449 |
Thailand | |
THA1: | Sathorn Nakorn Building, Floor 32, No. 100/68-69 North Sathon Road, |
Silom, Bangrak, Bangkok, 10500 | |
THA2: | 14th Floor, CTI Tower, 191/70-73 Ratchadapisek Road, Khwaeng |
Klongtoey, Klongtoey, Bangkok, 10110 | |
THA3: | The Offices at Central World, Office R06, 999/9 Rama I Road, |
Pathumwan, Bangkok 10330 | |
Turkey | |
TUR1: | Maslak Mah. Bilim Sokak Sun Plaza Kat:13 Sisli-Maslak, Istanbul |
TUR2: | Esentepe Mah. Ali Kaya Sk. Polat Plaza B Blok No: 1 /1b Sisli, Istanbul |
TUR3: | Tuyap Fuar ve Kongre Merkezi, Cumhuriyet Mah. Hadimkoy Yolu Cad. |
No:9/4 , 34500 Buyukcekmece, Istanbul | |
United Arab | |
Emirates | |
UAE1: | Office 303, 3rd Floor Arjaan Office Tower Al Sufouh Complex, PO Box |
502425, Dubai Media City, Dubai | |
UAE2: | Al Sufouh Complex, Office nos. 404, 405, 406 & 407, Dubai Media City, |
Dubai |
Registered offices | |
United Kingdom | |
GBR1: | 1-3 Strand, London, WC2N 5JR |
GBR2: | Quadrant House, The Quadrant, Sutton, Surrey, SM2 5AS |
GBR3: | Gateway House, 28 The Quadrant, Richmond, Surrey, TW9 1DN |
GBR4: | Lexis House, 30 Farringdon Street, London, EC4A 4HH |
GBR5: | Global Reach, Dunleavy Drive, Cardiff, CF11 0SN |
GBR6: | 125 London Wall, London, EC2Y 5AS |
GBR7: | 5 Oakwood Drive, Loughborough, LE11 3QF |
GBR8: | Biodata Innovation Centre Wellcome Genome Campus, Hinxton, |
Cambridge, CB10 1DR | |
United States | |
USA1: | 1000 Alderman Dr., Alpharetta, GA 30005 |
USA2: | 230 Park Ave, New York, NY 10169 |
USA3: | Suite 501, 1105 North Market St, Wilmington, DE 19801 |
USA4: | 1150 18th St, NW, Washington, DC 20036 |
USA5: | 9443 Springboro Pike, Miamisburg, OH 45342 |
USA6: | c/o Aon Insurance Managers (USA) Inc, 100 Bank Street, Suite 630 |
Burlington, Vermont 05401 | |
USA7: | #1095 Wilson, Ste 3, San Juan, PR 00907 |
Vietnam | |
VIE1: | 2nd Floor, Kova Center, 92G-92H Nguyen Huu Canh Street, Ward no. 22, |
District. Binh Thanh, Ho Chi Minh City |
Registration | |
Company name | number |
Aistemos Limited | 8644182 |
Butterworths Limited | 2826955 |
Crediva Limited | 6567484 |
Interfolio UK Ltd | 7820803 |
Mack-Brooks Exhibitions Limited | 967560 |
MLex Limited | 5488651 |
Offshore Europe (Management) Limited | 2318214 |
RE (RCB) Limited | 3396524 |
RE (SOE) Limited | 2330299 |
Reed Events Limited | 5893942 |
RELX (Holdings) Limited | 5807690 |
RELX (Investments) plc | 5810043 |
RELX Overseas Holdings Limited | 9489059 |
REV Venture Partners Limited | 4226986 |
SciBite Limited | 7778456 |
Tracesmart Limited | 3827062 |
2019 | 2020 | 2021 | 2022 | 2023 | |
£m | £m | £m | £m | £m | |
RELX consolidated financial information | |||||
Growth rates | |||||
Underlying revenue growth | +4% | -9% | +7% | +9% | +8% |
Underlying adjusted operating profit growth | +5% | -18% | +13% | +15% | +13% |
Adjusted earnings per share growth (at constant currency) | +7% | -15% | +17% | +10% | +11% |
Adjusted figures ¹ | |||||
Revenue | 7,874 | 7,110 | 7,244 | 8,553 | 9,161 |
EBITDA | 2,935 | 2,567 | 2,697 | 3,174 | 3,544 |
Operating profit | 2,491 | 2,076 | 2,210 | 2,683 | 3,030 |
Operating margin | 31.6% | 29.2% | 30.5% | 31.4% | 33.1% |
Profit before tax | 2,200 | 1,916 | 2,077 | 2,489 | 2,716 |
Net profit attributable to shareholders | 1,808 | 1,543 | 1,689 | 1,961 | 2,156 |
Net margin | 23.0% | 21.7% | 23.3% | 22.9% | 23.5% |
Cash flow | 2,402 | 2,009 | 2,230 | 2,709 | 2,962 |
Cash flow conversion | 96% | 97% | 101% | 101% | 98% |
Return on invested capital | 13.6% | 10.8% | 11.9% | 12.5% | 14.0% |
Earnings per share | 93.0p | 80.1p | 87.6p | 102.2p | 114.0p |
Dividend ² | |||||
Ordinary dividend per share | 45.7p | 47.0p | 49.8p | 54.6p | 58.8p |
Reported figures | |||||
Revenue | 7,874 | 7,110 | 7,244 | 8,553 | 9,161 |
Operating profit | 2,101 | 1,525 | 1,884 | 2,323 | 2,682 |
Profit before tax | 1,847 | 1,483 | 1,797 | 2,113 | 2,295 |
Net profit attributable to shareholders | 1,505 | 1,224 | 1,471 | 1,634 | 1,781 |
Net margin | 19.1% | 17.2% | 20.3% | 19.1% | 19.4% |
Net debt | 6,191 | 6,898 | 6,017 | 6,604 | 6,446 |
Earnings per share (pence) | 77.4p | 63.5p | 76.3p | 85.2p | 94.1p |